Oncolytic bacteria VNP20009 expressing IFNβ inhibits melanoma progression by remodeling the tumor microenvironment
Summary: In the tumor microenvironment (TME), tumor-associated NEs (TANs) have the potential to be protumorigenic or antitumorigenic within the TME in response to environmental cues. The diversity and plasticity of NEs (NEs) underlie the dual potential of TANs in the TME. Here, we utilized the tumor...
Main Authors: | Lina Liu, Qiang Li, Chen Chen, Wenjie Xin, Chao Han, Zichun Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224005935 |
Similar Items
-
Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma
by: Leyang Wu, et al.
Published: (2022-10-01) -
Therapeutic Effect of Recombinant Salmonella VNP20009-M on Osteosarcoma
by: ZHANG Xindan, et al.
Published: (2020-12-01) -
Anti-Tumor Effects of Engineered VNP20009-Abvec-Igκ-mPD-1 Strain in Melanoma Mice via Combining the Oncolytic Therapy and Immunotherapy
by: De-Xi Zhou, et al.
Published: (2022-12-01) -
Culture of attenuated Salmonella Typhimurium VNP20009 in animal-product-free media does not alter schwannoma growth control
by: Sherif G. Ahmed, et al.
Published: (2023-08-01) -
Comparison of Anticancer Activities and Biosafety Between Salmonella enterica Serovar Typhimurium ΔppGpp and VNP20009 in a Murine Cancer Model
by: Xiaoqing Liu, et al.
Published: (2022-06-01)